Eledon Pharmaceuticals (ELDN) Other Gross PP&E Adjustments (2016 - 2017)
Historic Other Gross PP&E Adjustments for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to -$276000.0.
- Eledon Pharmaceuticals' Other Gross PP&E Adjustments rose 6239.78% to -$276000.0 in Q3 2017 from the same period last year, while for Sep 2017 it was -$2.1 million, marking a year-over-year increase of 1234.98%. This contributed to the annual value of -$643000.0 for FY2016, which is 1032.08% up from last year.
- Per Eledon Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at -$276000.0 for Q3 2017, which was up 6239.78% from -$1.1 million recorded in Q1 2017.
- Eledon Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at -$266000.0 during Q4 2013, with a 5-year trough of -$1.1 million in Q1 2017.
- Over the past 5 years, Eledon Pharmaceuticals' median Other Gross PP&E Adjustments value was -$597000.0 (recorded in 2015), while the average stood at -$586153.8.
- In the last 5 years, Eledon Pharmaceuticals' Other Gross PP&E Adjustments plummeted by 9586.47% in 2014 and then surged by 6239.78% in 2017.
- Eledon Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$266000.0 in 2013, then plummeted by 95.86% to -$521000.0 in 2014, then plummeted by 37.62% to -$717000.0 in 2015, then increased by 10.32% to -$643000.0 in 2016, then surged by 57.08% to -$276000.0 in 2017.
- Its Other Gross PP&E Adjustments stands at -$276000.0 for Q3 2017, versus -$1.1 million for Q1 2017 and -$643000.0 for Q4 2016.